AU2402392A - New anti-diarrheic agents - Google Patents

New anti-diarrheic agents

Info

Publication number
AU2402392A
AU2402392A AU24023/92A AU2402392A AU2402392A AU 2402392 A AU2402392 A AU 2402392A AU 24023/92 A AU24023/92 A AU 24023/92A AU 2402392 A AU2402392 A AU 2402392A AU 2402392 A AU2402392 A AU 2402392A
Authority
AU
Australia
Prior art keywords
new anti
diarrheic
agents
diarrheic agents
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24023/92A
Inventor
Wolfgang Kromer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU2402392A publication Critical patent/AU2402392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
AU24023/92A 1991-08-06 1992-08-04 New anti-diarrheic agents Abandoned AU2402392A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4125955 1991-08-06
DE4125955 1991-08-06
CH75892 1992-03-10
DE4221584 1992-07-01
DE4221584 1992-07-01
CH758/92 1992-09-02

Publications (1)

Publication Number Publication Date
AU2402392A true AU2402392A (en) 1993-03-02

Family

ID=27172393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24023/92A Abandoned AU2402392A (en) 1991-08-06 1992-08-04 New anti-diarrheic agents

Country Status (2)

Country Link
AU (1) AU2402392A (en)
WO (1) WO1993002707A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657351B2 (en) * 1991-09-06 1995-03-09 Mcneilab, Inc. Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
WO1997014438A1 (en) * 1995-10-19 1997-04-24 The University Of Queensland Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist
US6362194B1 (en) 1992-09-21 2002-03-26 Albert Einstein College Of Medicine Of Yeshiva University Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
AU782475B2 (en) * 1993-07-27 2005-08-04 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ565683A (en) 2005-07-08 2011-04-29 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis in human neural cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390772A (en) * 1971-05-07 1975-04-16 Endo Lab Oral narcotic composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657351B2 (en) * 1991-09-06 1995-03-09 Mcneilab, Inc. Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
US6362194B1 (en) 1992-09-21 2002-03-26 Albert Einstein College Of Medicine Of Yeshiva University Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US7026329B2 (en) 1992-09-21 2006-04-11 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
AU782475B2 (en) * 1993-07-27 2005-08-04 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
WO1997014438A1 (en) * 1995-10-19 1997-04-24 The University Of Queensland Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist

Also Published As

Publication number Publication date
WO1993002707A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
AU6018194A (en) Easy intubator
AU655472B2 (en) Imidazodiazepines
AU653847B2 (en) Benzodioxanderivate
AU654362B2 (en) Pyrrolopyrazines
AU1782292A (en) Gridbeam
AU2135292A (en) Cyanophenylpyrroles
AU685767B2 (en) Substituted benzazepinones
AU1556892A (en) 2-substituted-2-imidazolines
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU1080292A (en) Ige-receptor-antibodies
AU2635592A (en) Thickening agents
AU1766292A (en) Ibuprofen-decongestant combinations
AU2586192A (en) Imaginograph
AU1752492A (en) Diamino-alpha-alkylstilbenes
AU1732692A (en) Substituted imidazolinylpyrimidines
AU647640B2 (en) Quinolin-2-yl-methoxybenzylhydroxyureas
AU2979992A (en) Quinolylmethoxyphenyl-acetamides
AU3018192A (en) Sulfonimidamides
AU2402392A (en) New anti-diarrheic agents
AU658903B2 (en) Snake-controlling agent
AU1669792A (en) Azabicycloheptanone
AU2521192A (en) Polyolefin-polyamine-N-substituted poly-carbamates
AU1624092A (en) Mopheads
AU1588892A (en) Watch-strap
AU4425593A (en) New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides